Beam Therapeutics Inc.
BEAM
16.99
USD+0.32
(+1.92%)Day's range
16.33
17.52
52 wk Range
13.525
35.25
BEAM Cash Flow
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -376,742,000 | -132,527,000 | -289,088,000 | -370,638,000 | -194,592,000 | -78,326,000 | -116,738,000 | -8,002,000 | |
| Depreciation & Amortization | 21,925,000 | 20,012,000 | 14,147,000 | 7,451,000 | 4,735,000 | 3,503,000 | 650,000 | 11,000 | |
| Deferred Income Tax | 0 | 0 | 0 | -16,765,000 | 63,518,000 | 4,480,000 | 11,749,000 | 500,000 | |
| Stock-Based Compensation | 0 | 98,647,000 | 84,321,000 | 43,570,000 | 15,380,000 | 7,028,000 | 7,002,000 | 198,000 | |
| Change in Working Capital | -110,223,000 | -116,455,000 | 251,628,000 | 111,254,000 | 5,347,000 | -10,705,000 | 10,075,000 | 740,000 | |
| Accounts Receivable Change | 0 | 0 | 300,000,000 | -300,000,000 | 0 | 0 | 0 | 0 | |
| Inventory Change | 0 | 0 | -300,000,000 | 300,000,000 | 0 | 0 | 0 | 0 | |
| Accounts Payable Change | 1,807,000 | -7,578,000 | 2,373,000 | 818,000 | 60,000 | 4,092,000 | 2,436,000 | 726,000 | |
| Other Working Capital Change | -112,030,000 | -108,877,000 | 249,255,000 | 110,436,000 | 5,287,000 | -14,797,000 | 7,639,000 | 14,000 | |
| Other Non-Cash Items | 7,571,000 | -18,872,000 | -38,481,000 | 158,860,000 | 9,871,000 | 2,017,000 | 66,964,000 | 3,846,000 | |
| Net Cash Provided by Operating Activities | -347,246,000 | -149,195,000 | 22,527,000 | -66,268,000 | -95,741,000 | -72,003,000 | -20,298,000 | -2,707,000 | |
| Investments in Property, Plant & Equipment | -8,946,000 | -33,732,000 | -48,951,000 | -46,811,000 | -16,357,000 | -12,518,000 | -13,124,000 | -346,000 | |
| Net Acquisitions | 0 | 0 | 412,385,000 | 620,000 | 83,766,000 | 54,141,000 | 0 | 0 | |
| Purchases of Investments | -486,439,000 | -984,338,000 | -1,616,999,000 | -777,223,000 | -282,362,000 | -130,210,000 | -300,000 | 0 | |
| Sales & Maturities of Investments | 680,392,000 | 1,089,910,000 | 1,204,614,000 | 529,270,000 | 198,596,000 | 76,069,000 | 0 | 0 | |
| Other Investing Activities | 0 | 0 | -412,385,000 | -247,953,000 | -83,766,000 | -54,141,000 | -300,000 | 0 | |
| Net Cash Used for Investing Activities | 185,007,000 | 71,840,000 | -461,336,000 | -294,144,000 | -100,123,000 | -66,659,000 | -13,424,000 | -346,000 | |
| Debt Repayment | -485,000 | -2,252,000 | -2,287,000 | -2,118,000 | 1,698,000 | 5,714,000 | 0 | 0 | |
| Common Stock Issued | 0 | 270,168,000 | 108,258,000 | 757,449,000 | 319,528,000 | 37,901,000 | 179,727,000 | 4,984,000 | |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | -25,187,000 | 0 | 0 | |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | -12,714,000 | 0 | 0 | |
| Other Financing Activities | 8,221,000 | 8,532,000 | 5,619,000 | 810,000 | 1,096,000 | 48,279,000 | 179,727,000 | 4,984,000 | |
| Net Cash Used/Provided by Financing Activities | 7,736,000 | 276,448,000 | 111,590,000 | 756,141,000 | 322,322,000 | 41,279,000 | 179,727,000 | 4,984,000 | |
| Effect of Forex Changes on Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Change in Cash | -154,503,000 | 199,093,000 | -327,219,000 | 395,729,000 | 126,458,000 | -97,383,000 | 146,005,000 | 1,931,000 | |
| Cash at End of Period | 290,111,000 | 444,614,000 | 245,521,000 | 572,740,000 | 177,011,000 | 50,553,000 | 147,936,000 | 1,931,000 | |
| Cash at Beginning of Period | 444,614,000 | 245,521,000 | 572,740,000 | 177,011,000 | 50,553,000 | 147,936,000 | 1,931,000 | 0 | |
| Operating Cash Flow | -347,246,000 | -149,195,000 | 22,527,000 | -66,268,000 | -95,741,000 | -72,003,000 | -20,298,000 | -2,707,000 | |
| Capital Expenditure | -8,946,000 | -33,732,000 | -48,951,000 | -46,811,000 | -16,357,000 | -12,518,000 | -13,124,000 | -346,000 | |
| Free Cash Flow | -356,192,000 | -182,927,000 | -26,424,000 | -113,079,000 | -112,098,000 | -84,521,000 | -33,422,000 | -3,053,000 |